American Board of Precision Medicine Advances Stratified Medicine Through Translational Research
The American Board of Precision Medicine is focusing on advancing stratified medicine, also known as precision medicine, by bridging the gap between emerging scientific discoveries and practical medical applications. This involves the use of biomarker discovery, preclinical modeling, and adaptive clinical trial design to ensure that promising research can be translated into effective patient treatments. The department is equipping clinicians with the necessary skills to carry discoveries through every stage of the translational continuum, from target validation to regulatory science and precision therapeutics. This approach aims to ensure that research findings are not just theoretical but are translated into real-world, patient-centered outcomes. 
